Clinical trials
Parkinsonism clinical trials
Below are recruiting parkinsonism clinical trials, each written for real people, not researchers. We’re tracking 746 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07371338RecruitingPhase 1
Testing a new drug for advanced Parkinson's
This trial tests an investigational drug called IPS101A in people with advanced Parkinson's disease. It aims to see if the drug is safe and how well it works when standard treatments are no longer enough.
SeoulAges 50–80 - NCT07386015Recruiting
Study of freezing of gait in Parkinson's disease
This study looks at people with Parkinson's disease or similar conditions who have walking problems like freezing of gait (feet feeling stuck) or balance issues. Researchers want to learn more about what causes these symptoms and how they affect people over time.
Tianjin, Tianjin MunicipalityAges 30–85 - NCT02760108Recruiting
Parkinson’s Families Project for people with family links
This project is for people age 16 and older who have Parkinson’s (or similar symptoms called parkinsonism). It focuses on people with a family history and/or symptoms that started before age 45, to better understand Parkinson’s in families.
LondonAges 16 years+ - NCT02194816Recruiting
Online survey study for people with Parkinson’s or Parkinsonism
This study looks at how changing certain factors over time relates to symptoms in Parkinson’s disease and related conditions. You may help researchers by completing longer online surveys every 6 months for 5 years.
Kenmore, WashingtonAges 19 years+ - NCT07422675RecruitingPhase 1
Study of a new treatment for Parkinson's with motor fluctuations
This study tests a new single-dose treatment for Parkinson's disease to see if it can help reduce 'off' time—when medication wears off and symptoms return. It is for people who experience motor fluctuations and are already on a stable medication routine.
Englewood, ColoradoAges 40–80 - NCT07442370Recruiting
Rotational exercises for fall risk in Parkinson's
This study tests if rotational exercises can lower fall risk and improve movement in people with early-stage Parkinson's. You would do simple, guided exercises over a set period.
Istanbul, SancaktepeAges 50–70 - NCT07554833Recruiting
Brain Stimulation for Parkinson's Motor and Memory Skills
This study tests whether repeated magnetic stimulation (rTMS) of the brain can help improve movement and thinking problems in people with Parkinson's disease. Researchers will measure how the treatment affects your motor control and cognitive function over the study period.
San Francisco, CaliforniaAges 50–90 - NCT07568951Recruiting
Hip Muscle Strength Study in Parkinson's Disease
This study compares how hip muscles work in people with and without Parkinson's disease. Researchers will measure your hip muscle strength and control to better understand how Parkinson's affects movement and balance.
TaoyuanAges 20–85 - NCT07599696Recruiting
Speech Amplification Devices for Parkinson Disease
This research study tests special amplification devices designed to help people with Parkinson disease or related conditions speak more clearly. The goal is to improve how well others can understand your speech.
East Lansing, MichiganAges 50 years+ - NCT07278297Enrolling by invitation
Parkinson ballroom fitness: dance for better movement and mood
This study tests whether personalized ballroom dancing can help improve both motor (movement) and nonmotor (mood, thinking) symptoms in people with Parkinson's. You would attend dance classes and testing sessions, possibly with a caregiver or family member.
Viborg, Central JutlandAges 40 years+ - NCT06817772Enrolling by invitation
Digital markers for movement in Parkinson's disease
This trial uses smartphone sensors to track movement in people with early-to-mild Parkinson's disease. It aims to find digital markers that help doctors better monitor symptoms and adjust treatments.
Madrid, MadridAges 30–80 - NCT04566341Enrolling by invitation
Study gut problems in Parkinson’s and changes in gut nerves
This study looks at how digestive (gut) problems happen in people with Parkinson’s and whether there are related changes in the nerve tissue in the digestive tract. It may help researchers better understand the cause of these symptoms and find new ways to monitor or treat them.
Boston, MassachusettsAges 40–85 - NCT07322887RecruitingPhase 2
Study of sul-238 for early untreated parkinson's disease
This study tests whether an experimental medicine called SUL-238 can improve energy levels in the brain cells of people with early, untreated Parkinson's. It uses a special type of MRI to see if the medicine affects brain energy.
GroningenAges 40 years+ - NCT06482268RecruitingPhase 1
Cell transplant for advanced parkinson's disease
This trial tests a new type of cell transplant for Parkinson's disease. The cells are made from stem cells and are meant to replace damaged brain cells that produce dopamine, which may improve your motor symptoms.
La Jolla, CaliforniaAges 40–75 - NCT07543861RecruitingPhase 1
Standing Balance Training Study for Parkinson's Disease
This study tests a new way to help people with Parkinson's disease improve their balance and standing ability through guided exercises in a lab setting. Researchers want to see if this approach can safely help reduce balance problems and fall risk.
Ann Arbor, MichiganAges 50 years+ - NCT07115563Recruiting
Amino acid supplement test for Parkinson's disease
This trial tests if taking daily amino acid supplements helps people with Parkinson's disease. You need to be on stable Parkinson's medication for at least 3 months.
Farmington, ConnecticutAges 50–90 - NCT07703137Enrolling by invitation
NAD Supplement for Parkinson's Disease Study
This study tests whether a supplement called NAD (a natural substance that helps cells produce energy) can improve symptoms in people with Parkinson's disease. You would take the supplement daily for several weeks, and researchers will check your movement, thinking, and overall well-being.
Oklahoma City, OklahomaAges 55–85 - NCT07513441RecruitingPhase 1
Testing Lu AF28996 for Parkinson's disease motor fluctuations
This early-stage trial tests a new medication called Lu AF28996 in Chinese patients with Parkinson's disease who experience predictable on-off episodes (times when medication works well versus poorly). The study aims to see if this drug can help reduce those difficult off periods.
Beijing, Beijing MunicipalityAges 35–85 - NCT06976268RecruitingPhase 2/Phase 3
Testing BHV-8000 for early Parkinson's disease
This study tests a new once-daily pill called BHV-8000 in people who were recently diagnosed with early Parkinson's disease and are not yet on medication. The goal is to see if it can slow the progression of symptoms and improve quality of life.
Birmingham, AlabamaAges 40–80 - NCT06449404Recruiting
7-Tesla MRI study of Parkinson's disease
This study uses a very powerful 7-Tesla MRI machine to take detailed pictures of the brain in people with Parkinson's disease. The goal is to better understand changes in the brain and possibly find new ways to track the disease.
Beijing, Beijing, ChinaAges 18–80 - NCT07005180RecruitingPhase 2
Carbon monoxide gas for Parkinson's disease
This trial tests if a low dose of carbon monoxide (HBI-002) is safe and helpful for people with Parkinson's disease. It requires specific health criteria and stable Parkinson's medication.
Fountain Valley, CaliforniaAges 40–80 - NCT07174310RecruitingPhase 3
Prasinezumab for early Parkinson's disease
This study tests a new medication called prasinezumab, given through a vein (IV), to see if it can slow the progression of early-stage Parkinson's disease. It is for people who are on only one Parkinson's medication and have not yet developed motor complications.
Birmingham, AlabamaAges 50–85 - NCT06932679Recruiting
How people with Parkinson’s cross obstacles
This study looks at how people with and without Parkinson’s disease see and step over obstacles while walking. It aims to understand differences in perception and movement to help improve safety and mobility for people with Parkinson’s.
HaifaAges 20–80 - NCT06859385Enrolling by invitation
Standing up test for Parkinson's patients
This study tests a simple way to measure how well people with Parkinson's can stand up from lying down. It aims to see if the test is reliable and useful for tracking movement over time.
Gaziantep, Gazi̇azntepAges 40–65
Hear when a new Parkinsonism trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for parkinsonism?
- Yes. Clin2 currently lists 746 recruiting parkinsonism studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a parkinsonism trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a parkinsonism trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.